Hepatitis and Human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California

Journal of Addictive Diseases

Volumn 25, Issue 2, 2006, Pages 25-32

  Fisher, Dennis G ^a   Reynolds, Grace L ^a   Jaffe, Adi ^a   Perez, Mario J ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b Office of AIDS Programs and Policy   (United States)

Author keywords

Co morbidity; Hepatitis; Hispanic; Human Immunodeficiency Virus; Injection drug use

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; DESIGNER DRUG; KETAMINE;

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; ETHNOLOGY; FEMALE; HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PREVALENCE; PRISON; QUESTIONNAIRE; RISK ASSESSMENT; SEXUAL BEHAVIOR; STATISTICAL SIGNIFICANCE; SUPERINFECTION; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CALIFORNIA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PRISONS; REGRESSION ANALYSIS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33746599024     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v25n02_04     Document Type: Article

References (53)

1. Weinberg MS, Hopkins J, Farrington L, Gresham L, Ginsberg M, Bell BP. Hepatitis A in Hispanic children who live along the United Stated-Mexico border: The role of international travel and food-borne exposures. Pediatrics 2004; 114:68-73.
2. Katz MH, Hsu L, Wong E, Liska S, Anderson L, Janssen RS. Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. Journal of Infectious Diseases 1997; 175:1225-29.
3. Tennant F, Moll D. Seroprevalence of hepatitis A, B, C, and D markers and liver function abnormalities in intravenous heroin addicts. Journal of Addictive Diseases 1995; 14:35-49.
4. Wells RS, Fisher DG, Fenaughty KE, Cagle HH, Jaffe A. Hepatitis A prevalence among injection drug users. Clinical Laboratory Science in press.
5. Hayes-Bautista DE, Baezconde-Garbanati L, Hayes-Bautista M. Latino health in Los Angeles: Family medicine in a changing minority context. Family Practice 1994; 11:318-24.
6. Centers for Disease Control and Prevention. Hepatitis A among drug abusers. Morb Mortal Wkly Rep, Vol. 37, 1988:297-300,305.
7. Harkess J, Gildon B, Istre GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-1987. American Journal of Public Health 1989; 79:463-6.
8. Shaw FE, Whiteman DC, Merritt AD, el-Saadi DM, Satfford RJ, Heel K, Smith GA. Hepatitis A outbreaks among illicit drug users and their contacts in Queensland. Medical Journal of Australia 1999; 170:584-7.
9. Leino T, Leinikki P, Hyypia T, Ristola M, Suni J, Sutinen J, Holopainen A, Haikala O, Valle M, Rostilo T. Hepatitis A outbreak among intravenous amphetamine users in Finland. Scandinavian Journal of Infectious Diseases 1997; 29:213-6.
10. Jin A, Bardsley J. Intravenous drug use and hepatitis A: An investigation of an outbreak. Canadian Journal of Public Health 1990; 81:79-81.
11. Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sexually Transmitted Diseases 2001; 28:166-70.
12. Kuhrt-Hunstiger TI, Fisher DG. Risk factors for Hepatitis B in Alaskan IVDUs. Arctic Medical Research 1994; 53:625-7.
13. Gelberg L, Robertson MJ, Leake B, Wenzel SL, Bakhtiar L, Hardie EA, Sadler N, Gutzug T. Hepatitis B among homeless and other impoverished U.S. military veterans in residential care in Los Angeles. Public Health 2001; 115:286-1.
14. Lopez-Zetina J, Kerndt P, Ford W, Woerhle T, Weber M. Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1966. Addiction 2001; 96:589-95.
15. Estrada AL. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Reports 2002; 117:S126-S34.
16. Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes 2003; 33:199-205.
17. Weinstock H, Spruill C, Lemp G, Altman R, Prevots R, Gwinn M. Hepatitis B and C as markers of HIV risk among injecting drug users, Newark, NJ, and San Francisco, CA. Paper presented at National Conference on Human Retroviruses and Related Infections, 1995.
18. Des Jarlais DC, Fisher DG, Newman JC, Trubatch BN, Yancovitz M, Paone D, Perlman D. Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs. on-site vaccination at a syringe exchange program. American Journal of Public Health 2001; 91:1791-2.
19. Fisher DG, Fenaughty AM, Paschane AE, Paschane DM, Cagle HH, Orr S. Hepatitis C virus among Alaskan drug users. American Journal of Public Health 1997; 87:1722-4.
20. Williams I. Epidemiology of hepatitis C in the United States. American Journal of Medicine 1999; 107:2S-9S.
21. Steering Committee and Working Group for the Prevention and Control of Hepatitis C in California. The hepatitis C strategic plan. Sacramento, CA: California Department of Health Services, Disease Investigations and Surveillance Branch, Hepatitis C Prevention and Control Unit, 2001:32.
22. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Marti D, Astemborski J, Carrington M. Racial differences in HLA Class II associations with hepatitis C virus outcomes. The Journal of Infectious Diseases 2001; 184:16-21.
23. Celona AF, Yu MC, Prakash M, Kuo T, Bonacini M. Hepatitis C in a Los Angeles public hepatitis clinic: Demographic and biochemical differences associated with race-ethnicity. Clinical Gastroenterology and Hepatology 2004; 2:459-62.
24. Bonacini M, Groshen S, Yu MC, Govindarajan S, Lindsay KL. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles county. American Journal of Gastroenterology 2001; 96:2438-41.
25. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes 1998; 18, Suppl 1:S6-S10.
26. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes 1998; 18 (Suppl 1):S11-S19.
27. Hagan H, Thiede H, Weiss NS, Hopkin SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91:42-5.
28. Ruiz JD, Molitor F, Sun RK, Mikanda J, Facer M, Colford JMJ, Rutherford GW, Ascher MS. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. Western Journal of Medicine 1999; 170:156-60.
29. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. American Journal of Gastroenterology 2000; 95:740-7.
30. McCarthy JJ, Flynn N. Hepatitis C in methadone maintenance patients: prevalence and public policy implications. Journal of Addictive Diseases 2001; 20:19-31.
31. Nyamathi AM, Dixon EL, Robbins W, Smith C, Wiley D, Leake B, Longshore D, Gelberg L. Risk factors for hepatitis C virus infection among homeless adults. Journal of General Internal Medicine 2002; 17:134-43.
32. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C infection in San Francisco's HIV-infected urban poor. Journal of General Internal Medicine 2004; 19:357-65.
33. Hagen H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt. Sinai Journal of Medicine 2000; 67:423-8.
34. Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. Journal of Clinical Microbiology 2000; 38:575-7.
35. Cagle HH, Fisher DG, Senter TP, Thurmond RD, Kastar AJ. Classifying skin lesions of injection drug users: A method for corroborating disease risk. Rockville, MD: Substance Abuse and Mental Health Services Administration, National Clearinghouse for Alcohol and Drug Information. (Inventory Number AVD154) www.samhsa.gov/centers/clearinghouse/clearinghouses.html, 2002.
36. Dowling-Guyer S, Johnson ME, Fisher DG, Needle R, Watters J, Anderson M, Williams M, Kotranski L, Booth R, Rhodes F, Weatherby N, Estrada AL, Fleming D, Deren S, Tortu S. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994; 1:383-92.
37. Fisher DG, Kuhrt-Hunstiger TI, Orr S, Davis DC. Hepatitis B validity of drug users' self-report. Psychology of Addictive Behaviors 1999; 13:33-8.
38. Schlicting EG, Johnson ME, Brems C, Wells RS, Fisher DG, Reynolds G. Validity of injecting drug users' self report of hepatitis A, B, and C. Clinical Laboratory Science 2003; 16:99-106.
39. Needle R, Weatherby N, Chitwood D, Booth R, Watters J, Fisher DG, Brown B, Cesari H, Williams ML, Andersen M, Braunstein M. Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors 1995; 9:242-50.
40. SAS Institute Inc. SAS/STAT 9.1 user's guide. Cary, NC: SAS Institute Inc., 2004.
41. Trubatch BA, Fisher DG, Cagle HH, Fenaughty AM. Vaccination strategies for targeted and difficult-to-access groups. American Journal of Public Health 2000; 90:447.
42. Siddiqui F, Mutchnick M, Kinzie J, Peleman R, Naylor P, Ehrinpreis M. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: Implications for vaccination strategy. American Journal of Gastroenterology 2001; 96:858-63.
43. Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: Implications for vaccination programs. Canadian Medical Association Journal 2001; 165:293-7.
44. Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: A latent variable approach. Drug and Alcohol Dependence 2004; 75:89-95.
45. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correction facilities. Journal of Urban Health: Bulletin of the New York Academy of Medicine 2004; 81:25-37.
46. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study. Gastroenterology 1999; 116:893-9.
47. Fisher DG, Fenaughty AM, Trubatch BA. Sero-conversion issues among out-of-treatment injection drug users. Journal of Psychoactive Drugs 1998; 30:299-306.
48. Fisher DG, Cagle HH, Queen PJ, Hosmer D. Needle sharing among IVDUs in Anchorage, Alaska. Paper presented at Tenth International Conference on AIDS, Yokohama, Japan, 1994.
49. Anderson JC, Simonetti J, Fisher DG, Williams J, Yamamura Y, Rodriguez N, Sullivan DG, Gretch DR, McMahon B, Williams K. Comparison of different HCV viral load and genotyping assays. Journal of Clinical Virology 2003; 28:27-37.
50. Beauvais F, Oetting ER, Wolf W, Edwards RW. American Indian youth and drugs, 1976-87: A continuing problem. American Journal of Public Health 1989; 79:634-6.
51. Fenaughty AM, Fisher DG, Cagle HH, Stevens S, Baldwin JA, Booth R. Sex partners of Native American drug users. Journal of Acquired Immune Deficiency Syndromes 1998; 17:275-82.
52. Fisher DG, Cagle HH, Wilson PJ. Drug use and HIV risk in Alaska Natives. Drugs & Society 1993; 7:107-17.
53. Metler R, Conway GA, Stehr-Green J. AIDS surveillance among American Indians and Alaska natives. American Journal of Public Health 1991; 81:1469-71.